Walder Wyss advised Versant Ventures on the deal. VISCHER advised Cimeo Therapeutics. Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel...
You must be a Standard 1 Year member to access this content.
Bär & Karrer advised kooky in this transaction. Walder Wyss advises UVC Partners. The start-up kooky has completed financing round of over six million Euro. In...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Adjuvant Capital. Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced the close of an oversubscribed Series B...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as Swiss legal counsel for Alloy Therapeutics Inc on the deal. Vischer advised deepCDR Biologics AG. Alloy Therapeutics, a biotechnology ecosystem company, acquired...
You must be a Standard 1 Year member to access this content.
Walder Wyss advises Perconex Holding GmbH on the deal. The Frankfurt-based legal services company PERCONEX Holding GmbH announced the acquisition of Flex Suisse AG. Flex Suisse AG...
You must be a Standard 1 Year member to access this content.
Vischer advised GlycoEra AG on the deal. Walder Wyss advised 5AM Ventures, Roche Venture Fund and Sofinnova Partners as lead investors. GlycoEra AG has closed CHF...
You must be a Standard 1 Year member to access this content.
VISCHER AG advises Polyphor AG on the deal. Walder Wyss advises Enbiotix Inc. on this transaction. Polyphor (SIX: POLN) and EnBiotix Inc., a privately held late...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Alentis Therapeutics AG on the deal. Alentis Therapeutics AG announced a USD 67m series B financing round. Morningside Venture Investments led the financing, joined...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the proLogistik group on the deal. Kellerhals Carrard advised DRS Investment GmbH. The private investment company DRS Investment GmbH has sold all shares...
You must be a Standard 1 Year member to access this content.
